Author | Year | Intervention | Time before extubation | Intervention group | Control group | |||||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | Outcome parameter | Number | Percentage | Outcome parameter | Number | Percentage | P value |
Darmon et al. [12] | 1992 | Dexamethasone 8Â mg i.v. | 1Â hour | Laryngeal edema | 11/327 | 3.4Â % | Laryngeal edema | 17/337 | 5.0Â % | ns |
Ho et al. [17] | 1996 | Hydrocortisone 100Â mg i.v. | 1Â hour | Laryngeal edema | 7/39 | 17.9Â % | Laryngeal edema | 10/38 | 26.3Â % | ns |
Cheng et al. [16] | 2006 | Methylprednisolone 40Â mg i.v. | 24Â hours | Stridor | 5/43 | 11.6Â % | Stridor | 13/43 | 30.2Â % | 0.15 |
Reintubation | 3/43 | 6.9Â % | Reintubation | 11/43 | 25.6Â % | NA | ||||
 |  | Methylprednisolone 4 × 40 mg i.v. | 24 hours | Stridor | 3/42 | 7.1 % | Stridor | 13/43 | 30.2 % | 0.005 |
Reintubation | 7/42 | 16.7Â % | Reintubation | 11/43 | 25.6Â % | NA | ||||
François et al. [11] | 2007 | Methylprednisolone 3 × 20 mg i.v. | 12 hours | Laryngeal edema | 11/355 | 3.1 % | Laryngeal edema | 76/343 | 22. % | <0.01 |
Reintubation | 13/355 | 3.7Â % | Reintubation | 36/343 | 10.5Â % | 0.02 | ||||
Lee et al. [30]a | 2007 | Dexamethasone 4 × 5 mg i.v. | 48 hours | Stridor | 4/40 | 10 % | Stridor | 11/40 | 27.5 % | 0.037 |
Reintubation | 1/40 | 2.5Â % | Reintubation | 2/40 | 5.0Â % | 0.56 | ||||
Cheng et al. [26]b | 2011 | Methylprednisolone 40Â mg i.v. | 4Â hours | Stridor | 6/38 | 15.8Â % | Stridor | 13/33 | 39.4Â % | 0.025 |
Reintubation | 3/38 | 7.9Â % | Reintubation | 10/33 | 30.3Â % | NA | ||||
Abbasi et al. [29] | 2014 | Budesonide 4 × 1 mg nebulized | 48 hours | Respiratory distress | 3/35 | 8.6 % | Respiratory distress | 11/35 | 31.4 % | 0.017 |
Stridor | 3/35 | 8.6Â % | Stridor | 7/35 | 20Â % | 0.17 | ||||
Reintubation | 3/35 | 8.6Â % | Reintubation | 11/35 | 31.4Â % | 0.017 |